Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. MRNA
MRNA logo

MRNA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MRNA News

Moderna Stock Drops 7.49% Amid Earnings Anticipation

2d agoNASDAQ.COM

Moderna and Kodak Options Show High Trading Volume

2d agoNASDAQ.COM

Investment Outlook for Healthcare Stocks

3d agoFool

Biotech Companies Show Promising Clinical Progress

3d agoNASDAQ.COM

Trump Administration Delays Nomination for CDC Director

4d agoseekingalpha

Moderna's Vaccine Business Recovery

4d agoFool

Moderna's Vaccine Business Rebounds

4d agoNASDAQ.COM

Trump Administration Considers Candidates for CDC Leadership

Mar 21 2026seekingalpha

ImmunityBio's Anktiva Gains New Approvals and Momentum

Mar 20 2026stocktwits

Pfizer vs. Moderna: Vaccine Market Competition Analysis

Mar 19 2026Fool

Investment Comparison: Pfizer vs. Moderna

Mar 19 2026NASDAQ.COM

mRNA Vaccine Stocks Rise as HHS Committee Revises Recommendations

Mar 11 2026seekingalpha

BioNTech's Strategic Shift and Clinical Progress

Mar 10 2026Benzinga

BioNTech Announces Earnings, But That's Not the Reason for the 17% Drop in Stock Price.

Mar 10 2026Barron's

FDA CBER Head Dr. Vinay Prasad to Depart, Impact on Moderna and Rare Disease Stocks

Mar 09 2026Benzinga

Surge in Oil Prices Triggers Market Turmoil

Mar 09 2026CNBC